Funding None of the authors received any funding for this manuscript
Key Takeaways GLP-1 injection site reactions can include redness, itching, rash, bruising, swelling, pain, lumps, or thicker skin
The ultimate classification of GLP-1 agonists as game-changing or overhyped will depend on societys ability to address the implementation challenges that currently limit their transformative potential
Medical Monitoring Regular assessment of bone health is essential for those on GLP-1 medications: Baseline DEXA scan : Consider getting a bone density test before starting GLP-1 medication Follow-up testing : Repeat every 1-2 years while on medication Blood tests : Check vitamin D, calcium, and bone turnover markers annually Height measurement : Loss of height can be an early warning sign of vertebral fractures Conclusion GLP-1 medications offer powerful benefits for weight management and diabetes control
Concerned About Your Health
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update